top of page

A High-Performance Platform for Next-Generation Human Biomaterials

qmatrix-removebg-preview_edited.png
mev.jpeg
About

What we do

        Our purpose is to be the edge of innovation, delivering a new generation of human and biocompatible biomaterials to revolutionize biomedical research and medical devices.

       Tissue engineering and medical applications will never be the same.

        Our purpose is to be the edge of innovation, delivering a new generation of human and biocompatible biomaterials to revolutionize biomedical research and medical devices.

       Tissue engineering and medical applications will never be the same.

BIA - BIOFABRICATION INTELLIGENT ASSISTANT

From Biofabrication Design to Regulatory Approval — Powered by AI

Meet BIA, Quantis’ intelligent engine for biofabrication.
 

Accelerate your tissue and scaffold development with up to 70% reduction in trial-and-error, 50% faster protocol design, and 40% gains in reproducibility.

 

From bioink formulation to bioprinting parameters, architecture design and regulatory pathways, BIA transforms complex workflows into guided, data-driven decisions — reducing development time, lowering costs, and increasing success rates.

 

Design smarter. Print better. Validate faster. Translate sooner.

Relatório Mensal - Novembro.png

We create new products with bold industry leaders
and innovators.

By developing the first ever human biomaterials through our patented bioprocess, we are now searching for potential partners to develop together with us new medical devices and applications using our human collagen matrix.

Do you want to team up with us?

Awards and Recognition

With innovative solutions in the field of biotechnology, Quantis has gained recognition through its participation in competitions around the world!

Meet the Team

We are a quantum team driven by science, purpose, and meaningful real-world impact.

  • We unite technical excellence, deep innovation, and a strong sense of human responsibility.

  • Our work is collaborative, ethical, and firmly focused on real applications.

  • We value autonomy, diversity, and continuous learning as engines of growth.

  • We transform human biology into precise, next-generation regenerative solutions.

QUEM SOU EU - SITE (5).png

Janaina

Dernowsek

CEO

  • LinkedIn
QUEM SOU EU - SITE (2).png

Thais Amaral

Biofabrication Analyst

  • LinkedIn
QUEM SOU EU - SITE.png

Kamila Leichtweis

Operations Leader

  • LinkedIn
QUEM SOU EU - SITE (1).png

Vitor

Mattos

Bioink Analyst

  • LinkedIn
Oi, sou Lucas Guarnier! (2).png

Lucas Guarnier

Innovation Leader & Backstage

  • LinkedIn
QUEM SOU EU - SITE (5).png

Julie

Sanday

Intern in 3D Biomanufacturing

  • LinkedIn
QUEM SOU EU - SITE (3).png

Gabriela Morais

Innovation Coordinator

  • LinkedIn
QUEM SOU EU - SITE (4).png

Nathan Benelli

Biosystems Analyst

  • LinkedIn
Contact

Contact Us

Trusted and supported by

bndes-logoAtivo-4.png
aceleradora
brazil
brasil
empretec-sebrae_edited-removebg-preview.png
fapesp
startups

CNPJ 38.213.361/0001-99

©2020 - 2026 Quantis Biotechnology

Rua: Domingos Jorge 1100 - Vila Socorro 

CEP: 04779-900 - São Paulo - Brasil​

Delivery : 7 - 28 days

  • Instagram
  • LinkedIn
bottom of page